Society Letters

Letter Requesting Waiver of In-Person Visit Requirement for Insulin Pump Coverage

February 08, 2021

To Gift Tee, Director, Practitioner Services, Centers for Medicare and Medicaid Services

The Endocrine Society appreciates the efforts taken by CMS to expand telehealth access during the COVID-19 pandemic using the authority granted by the public health emergency declaration. These flexibilities have allowed people with diabetes and other chronic conditions to continue receiving medical care while avoiding unnecessary exposure to COVID-19. We respectfully request that you consider waiving the in-person visit requirements pertaining to coverage of insulin pumps and supplies for the duration of the public health emergency."

arrowRead the Full Letter

Last Updated:
Take Action

Make Your Voice Heard

We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.